dihexa cancer risk c-met D I H E X A is having a moment right now… and I get why. When something gets labeled as “brain repair” or “synapse growth,” it spreads FAST especially in communities A novel c-Met/TRK inhibitor 1D228
A novel c Met TRK inhibitor 1D228 efficiently inhibits tumor growth by targeting angiogenesis and tumor cell proliferation Cell Death & Disease Dihexa: Enhancing Cognitive Function Effectively c MET: A Key Target in Cancer Therapy Targeting of c MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma: Cell Reports Medicine
Pay in 4 interest-free payments of $5.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



